Riskpilot← Back to searchSign inGet full accessDr Wei AB
ABActiveOrg 5590463740Frejgatan 81 BTraditional, complementary and alternative medicine activities · NACE 8696Est. 20161 employees
Revenue 2024
SEK 515K
-10% vs 2023
EBITDA margin
11.3%
-41% vs 2023
Equity ratio
84.4%
Financial strength
Net profit 2024
SEK 47K
-19% vs 2023
| Revenue | SEK 515K | -10% |
| EBITDA | SEK 58K | -41% |
| Net profit | SEK 47K | -19% |
| Total assets | SEK 326K | +35% |
| Equity | SEK 275K | +102% |
| Employees | 1 | — |
Legal name
Dr Wei AB
Org number
5590463740
Legal form
Aktiebolag
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
8 januari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Kinesisk diagnos, akupunktur, massage, koppning, Guasha, Qigong, Thai Chi, meditation, yoga och kinesisk naturmedicin med verksamhet inom sjukvård, idrottsskador och friskvård. Konsultverksamhet och egen verksamhet inom import från Kina och export till Kina med kinesisk naturmedicin, vitaminer, kosttillskott och kontorsprodukter för grossister, detaljister och privatpersoner. Konsultation, rådgivning, kurser, utbildnings- och tema dagar, konferenser, seminarier, studieresor, föreläsning och personlig utveckling samt därmed förenlig verksamhet.
Address
Frejgatan 81 B
Email
info@drwei.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 180 | 375 | 201 | 395 | 533 | 573 | 515 |
| Staff expenses | — | — | — | — | — | — | −560 | — | — |
| EBITDA | −199 | 17 | −28 | 108 | 40 | 57 | −120 | 98 | 58 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −4 | −18 | −21 | −20 | −0 |
| EBIT | −199 | 17 | −28 | 108 | 36 | 39 | −141 | 78 | 58 |
| Net financials | — | — | — | — | — | — | −1 | −1 | 1 |
| Profit before tax | −200 | 17 | −28 | 107 | 36 | 39 | −143 | 58 | 59 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 | −12 |
| Net profit | −200 | 17 | −28 | 107 | 36 | 39 | −143 | 58 | 47 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 139 | 81 | 138 | 302 | 244 | 273 | 234 | 241 | 326 |
| Equity | 26 | 42 | 39 | 146 | 182 | 221 | 78 | 136 | 275 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 |
| Short-term debt | 113 | 39 | 99 | 156 | 62 | 52 | 155 | 105 | 31 |
| Total debt | 113 | 39 | 99 | 156 | 62 | 52 | 155 | 105 | 31 |
EBITDA margin
11.3%
This company
15.8%
Market median
-28% vs market
20162024
Equity ratio
84.4%
This company
38.2%
Market median
+121% vs market
20162024
Return on equity
17.1%
This company
18.4%
Market median
+7% vs market
20162024
Net profit margin
9.1%
This company
8.1%
Market median
+12% vs market
20162024
Asset turnover
1.58×
This company
1.12×
Market median
+41% vs market
20162024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HL | Board of Directors | 2023 | — | — |
| Deputy Board Member | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Wei AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hua Li | Board of Directors | 0 companies |
| Winnie Wei | Deputy Board Member | 0 companies |
| Joanna Zhang | Chairman | 0 companies |
| William Wang Jiang | Board of Directors | 0 companies |